Peer-generated best practices, guidance documents, and session highlights
How biopharma brands can find ways to break through the clutter with powerful brand content In a world where the average person is exposed to
What lies ahead for Biopharma and MedTech field teams? Ok, 2022 is off to an auspicious start for biopharma & MedTech… or is it? Big
Brand: 509 brand drugs have increased by an average of 5.0%
Generic: 8 generic drugs have increased by an average of 4.2%
Total: 517 drugs in total have increased by an average of 5.0%
Customer relationship management systems are not the same as content delivery platforms. Since the customer experience is about the successful transfer of information and value, biopharma and medtech companies need to ensure their technology enables value transfer elegantly, everytime.
We gathered speakers and attendees from Digital Pharma East to share their experience at this face to face event as well as share the highlights
The augmented and virtual reality industries are growing exponentially. Quite interestingly, the pharma industry has been quick to jump the bandwagon, using virtual reality to its advantage.
The digital transformation underway has touched most aspects of society– changing the way we shop, travel, interact with one another, and how we are entertained. This renaissance has also left an indelible mark on Life Science companies.
The stakes have never been higher for biotech, pharma, and medtech sales organizations. We explore ways that medical affairs, sales, and all customer-facing professionals can exceed the expectations of their customers and companies.
Nowadays, healthcare institutions are using electronic health records to manage information and capture data from patient appointments. Additionally, the data includes personal health records, reimbursement information, patient portals, and much more.
Delivering and Delighting HCP’s Everyone in the biopharmaceutical and MedTech space knows that customer-facing teammates need to win the attention of the health care professionals
The Stakes Have Never Been Higher For The $1.3T Biopharmaceutical Industry The Covid-19 pandemic has changed how we live, and especially how we work. With
Eric Gubera, EVP of the Life Science Practice at ARSENAL ADVISORS discusses the challenges biopharma and medtech organizations are facing as they compete for HCP engagement with MobileLocker’s Chief Revenue Officer Bob Lempke.
The term virtual interaction leads our brain cells to one thought: video games. The gaming industry has been leveraging virtual interaction to enhance the user experience for quite some time. Virtual interactive technologies have crossed the boundaries of gaming into an exciting new frontier–healthcare.
We sit down with Hans Kaspersetz of Relevate + Arteric to help us turn data into insights
Frank Dolan spoke with Joe Mullings for this edition of the ARSENAL Leader Lab series. As CEO of the Mullings Group Companies and Chief Vision Officer for MRINetwork, Mullings had extensive knowledge to offer.
ARSENAL Life Science is a division of ARSENAL ADVISORS, LLC.
Empowering life science industry leaders with exclusive content, networking, and data-driven decision making tools.
